Top

Published in:

01-03-2014 | Editorial Commentary

Liver–kidney transplantation to cure atypical HUS: still an option post-eculizumab?

Author: Jeffrey Saland

Published in: Pediatric Nephrology | Issue 3/2014

Abstract

Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.

Tran H, Chaudhuri A, Concepcion W, Grimm P (2013) Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Pediatr Nephrol. doi:10.1007/s00467-013-2630-5

Saland JM, Ruggenenti P, Remuzzi G (2009) Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 20:940–949PubMedCrossRef

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nurnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169–2181PubMedCrossRef

Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676–1687PubMedCrossRef

Verhave JC, Westra D, van Hamersvelt HW, van Helden M, van de Kar NC, Wetzels JF (2013) Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome. Neth J Med 71:342–347PubMed

Zuber J, Le Quintrec M, Morris H, Fremeaux-Bacchi V, Loirat C, Legendre C (2013) Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. Transplant Rev (Orlando) 27:117–125CrossRef

Stegall MD, Diwan T, Raghavaiah S, Cornell LD, Burns J, Dean PG, Cosio FG, Gandhi MJ, Kremers W, Gloor JM (2011) Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 11:2405–2413PubMedCrossRef

Cheong HI, Lee BS, Kang HG, Hahn H, Suh KS, Ha IS, Choi Y (2004) Attempted treatment of factor H deficiency by liver transplantation. Pediatr Nephrol 19:454–458PubMedCrossRef

Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 359:1671–1672PubMedCrossRef

10.

Remuzzi G, Ruggenenti P, Colledan M, Gridelli B, Bertani A, Bettinaglio P, Bucchioni S, Sonzogni A, Bonanomi E, Sonzogni V, Platt JL, Perico N, Noris M (2005) Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation. Am J Transplant 5:1146–1150PubMedCrossRef

11.

Loirat C, Saland J, Bitzan M (2012) Management of hemolytic uremic syndrome. Presse Med 41:e115–e135PubMedCrossRef

12.

Saland JM, Emre SH, Shneider BL, Benchimol C, Ames S, Bromberg JS, Remuzzi G, Strain L, Goodship TH (2006) Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 6:1948–1952PubMedCrossRef

13.

Kavanagh D, Richards A, Goodship T, Jalanko H (2010) Transplantation in atypical hemolytic uremic syndrome. Semin Thromb Hemost 36:653–659PubMedCrossRef

14.

Jalanko H, Peltonen S, Koskinen A, Puntila J, Isoniemi H, Holmberg C, Pinomaki A, Armstrong E, Koivusalo A, Tukiainen E, Makisalo H, Saland J, Remuzzi G, de Cordoba S, Lassila R, Meri S, Jokiranta TS (2008) Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 8:216–221PubMed

15.

Haller W, Milford DV, Goodship TH, Sharif K, Mirza DF, McKiernan PJ (2010) Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H. Am J Transplant 10:2142–2147PubMedCrossRef

16.

Neidich AB, Neidich EM, Lee A, Nicoletta J, Rohrer RJ, Milner LS, Cooper JT (2013) Novel use of immunoglobulin G in complement factor H missense mutation: a case report. Prog Transplant 23:213–216PubMedCrossRef

17.

Forbes TA, Bradbury MG, Goodship TH, McKiernan PJ, Milford DV (2013) Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series. Pediatr Transplant 17:E93–E99PubMedCrossRef

18.

Saland JM, Shneider BL, Bromberg JS, Shi PA, Ward SC, Magid MS, Benchimol C, Seikaly MG, Emre SH, Bresin E, Remuzzi G (2009) Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:201–206PubMedCrossRef

19.

Sanchez-Corral P, Melgosa M (2010) Advances in understanding the aetiology of atypical haemolytic uraemic syndrome. Br J Haematol 150:529–542PubMedCrossRef

20.

Alonso A, Melgosa M, lopez-Trascasa M, Navarro G, De la vega A, Sanchez-Corral P (2011) El trasplante hepático y renal combinado (THRC) normaliza el complemento y evita la recidiva del síndrome hemolítico urémico (SHU) atípico por mutación en el factor B [Abstract]. An Pediatr (Barc) 75:e1–e14

21.

Wilson C, Torpey N, Jaques B, Strain L, Talbot D, Manas D, Goodship T (2011) Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H. Am J Kidney Dis 58:109–112PubMedCrossRef

Title: Liver–kidney transplantation to cure atypical HUS: still an option post-eculizumab?
Author: Jeffrey Saland
Publication date: 01-03-2014
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 3/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-013-2722-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Liver–kidney transplantation to cure atypical HUS: still an option post-eculizumab?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Risk factors for early relapse during maintenance therapy after a single infusion of rituximab in children with steroid-dependent nephrotic syndrome

Corticosteroid therapy can be delayed but not omitted in idiopathic tubulointerstitial nephritis

Renal consequences of parenteral nutrition

Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study

Likelihood of children with end-stage kidney disease in Europe to live with a functioning kidney transplant is mainly explained by nonmedical factors

Citrate anticoagulation for continuous renal replacement therapy in small children